Annals of B Pod: Anti-Xa Overdose
Taming the SRU
FEBRUARY 12, 2024
DISCUSSION Epidemiology and Background Rivaroxaban, along with other direct oral anticoagulants (DOACs), has become a mainstay of treatment for pro-thrombotic conditions since 2011. [1] The patient is agitated on a backboard with C-collar in place. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. Samana, MM.
Let's personalize your content